Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Hypophosphatasia (HPP) is more than a bone disease, because low alkaline phosphatase activity disrupts how cells generate and use energy, leading to muscle weakness, exercise intolerance, chronic pain, and profound fatigue even when X-rays look normal. Vitamin B6 (pyridoxal 5'-phosphate) processing is impaired, which can contribute to seizures in infants and headaches, neuropathic pain, or mood and cognitive changes in adults. Other non-skeletal signs include early tooth loss, breathing difficulty, kidney calcium deposits, and gastrointestinal symptoms, and severity varies widely from person to person. Because these symptoms overlap with fibromyalgia, chronic fatigue, and mitochondrial disorders, many adults are misdiagnosed for years. There are several important factors to consider, including which lab values and specialist referrals matter most, so see below to understand more.
If your fatigue, muscle weakness, or unexplained pain has never added up to a clear diagnosis, mapping your full symptom pattern is the fastest way to move forward. A free, instant, online symptom check asks the same kinds of questions a clinician would, then helps you see which conditions fit your picture and which specialty is best suited to evaluate you. It takes only a few minutes, requires no insurance or appointment, and gives you a clear, organized summary you can bring to your next visit so nothing gets dismissed as "just stress." Rare and under-recognized conditions like HPP are found when someone finally connects the scattered clues, and that person can be you.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) is a rare genetic disorder caused by low or absent activity of the enzyme alkaline phosphatase. While most discussions focus on its effects on bone mineralization, HPP can also impair cellular energy metabolism. In this article, we explore how low alkaline phosphatase causes fatigue and other non-skeletal symptoms, why these issues arise, and what you can do about them.
Alkaline phosphatase (ALP) is an enzyme found throughout the body. Its best-known role is to help mineralize bone and teeth by breaking down inorganic pyrophosphate, an inhibitor of mineral deposition. But ALP also:
When ALP activity is deficient—as in HPP—these processes all suffer to some degree. The result can include broad effects on muscle, nerve, and energy metabolism.
Yes. Low ALP activity in HPP patients may directly contribute to feelings of fatigue and muscle weakness. Here’s how:
People with HPP may notice a variety of symptoms that don’t involve bones. Common non-skeletal signs include:
HPP severity varies based on how much ALP activity remains:
Even in mild cases, the chronic energy shortfall can impact quality of life, work performance, and mental health.
If you suspect HPP or experience unexplained fatigue with low ALP levels, a thorough evaluation is key:
While HPP can’t be “cured” yet, several strategies can help manage energy deficits:
Chronic fatigue has many causes. If you have persistently low alkaline phosphatase on blood tests coupled with unexplained tiredness, muscle weakness, or other HPP-related signs, consider a deeper evaluation. You might even start with a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you understand potential causes and next steps.
Always discuss any serious or life-threatening symptoms—such as seizures, sudden worsening of fatigue, or new neurological deficits—with a doctor immediately. Early intervention in HPP can improve long-term outcomes and quality of life.
Hypophosphatasia is more than a bone disorder. Low alkaline phosphatase activity can disrupt vitamin B6 processing, cellular energy production, and even neurotransmitter balance, leading to fatigue and other non-skeletal symptoms. By recognizing these connections, you and your healthcare team can pursue targeted testing, treatments, and lifestyle adjustments to manage energy deficits effectively.
For a personalized assessment of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. And always speak to a doctor about any worrisome or severe issues—especially those that could be life threatening or serious.
(References)
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Salles JP. Clinical Forms and Animal Models of Hypophosphatasia. Subcell Biochem. 2015;76:3-24. doi: 10.1007/978-94-017-7197-9_1. PMID: 26219704.
* Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R. Hypophosphatasia: From Diagnosis to Treatment. Curr Rheumatol Rep. 2018 Sep 10;20(11):69. doi: 10.1007/s11926-018-0778-5. Epub 2018 Sep 10. PMID: 30203264.
* Colazo JM, Hu JR, Dahir KM, Simmons JH. Neurological symptoms in Hypophosphatasia. Osteoporos Int. 2019 Feb;30(2):469-480. doi: 10.1007/s00198-018-4691-6. Epub 2018 Sep 13. PMID: 30215116.
* Briolay A, Bessueille L, Magne D. TNAP: A New Multitask Enzyme in Energy Metabolism. Int J Mol Sci. 2021 Sep 28;22(19). doi: 10.3390/ijms221910470. Epub 2021 Sep 28. PMID: 34638808; PMCID: PMC8509042.
* Collins MT, Marcucci G, Anders HJ, Beltrami G, Cauley JA, Ebeling PR, Kumar R, Linglart A, Sangiorgi L, Towler DA, Weston R, Whyte MP, Brandi ML, Clarke B, Thakker RV. Skeletal and extraskeletal disorders of biomineralization. Nat Rev Endocrinol. 2022 Aug;18(8):473-489. doi: 10.1038/s41574-022-00682-7. Epub 2022 May 16. PMID: 35578027.
* Montero-Lopez R, Farman MR, Högler F, Saraff V, Högler W. Challenges in Hypophosphatasia: Suspicion, Diagnosis, Genetics, Management, and Follow-Up. Horm Res Paediatr. 2025;98(6):736-745. doi: 10.1159/000540692. Epub 2024 Aug 5. PMID: 39102795.
* Ganjeh AM, Gomes A, Barreira MJ, Pinto CA, Casal S, Saraiva JA. Effects of pressure-based technologies on food lipids oxidation. Food Chem. 2024 Dec 15;461:140768. doi: 10.1016/j.foodchem.2024.140768. Epub 2024 Aug 5. PMID: 39181051.
* Dahir KM, Dunbar NS. Medical Management of Hypophosphatasia: Review of Data on Asfotase Alfa. Curr Osteoporos Rep. 2025 Mar 18;23(1):14. doi: 10.1007/s11914-025-00906-5. Epub 2025 Mar 18. PMID: 40100438; PMCID: PMC11920343.
* Montero-Lopez R, Farman MR, Högler F, Rehder C, Malli T, Webersinke G, Rockman-Greenberg C, Dahir K, Martos-Moreno GÁ, Linglart A, Ozono K, Seefried L, Del Angel G, Nading EB, Huggins E, Rush ET, Tauer JT, Kishnani PS, Högler W. Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants. J Bone Miner Res. 2026 Mar 2;41(3):259-269. doi: 10.1093/jbmr/zjaf124. PMID: 41042986; PMCID: PMC13017406.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.